The PIK3CA gene is mutated with high frequency in human breast cancers - PubMed (original) (raw)
Comparative Study
doi: 10.4161/cbt.3.8.994. Epub 2004 Aug 26.
Pedram Argani, Yardena Samuels, Natalie Silliman, Janine Ptak, Steve Szabo, Hiroyuki Konishi, Bedri Karakas, Brian G Blair, Clarence Lin, Brock A Peters, Victor E Velculescu, Ben Ho Park
Affiliations
- PMID: 15254419
- DOI: 10.4161/cbt.3.8.994
Comparative Study
The PIK3CA gene is mutated with high frequency in human breast cancers
Kurtis E Bachman et al. Cancer Biol Ther. 2004 Aug.
Erratum in
- Cancer Biol Ther. 2005 Feb;4(2):133
Abstract
The phosphatidylinositol 3-kinases (PI3Ks) are known regulators of cellular growth and proliferation. It has recently been reported that somatic mutations within the PI3K subunit p110alpha (PIK3CA) are present in human colorectal and other cancers. Here we show that thirteen of fifty-three breast cancers (25%) contain somatic mutations in PIK3CA, with the majority of mutations located in the kinase domain. These results demonstrate that PIK3CA is the most mutated oncogene in breast cancer and support a role for PIK3CA in epithelial carcinogenesis.
Comment in
- PI3K: Missense Mutation Motivates Malignancy.
Hawthorne VS, Yu D. Hawthorne VS, et al. Cancer Biol Ther. 2004 Aug;3(8):776-7. doi: 10.4161/cbt.3.8.1031. Epub 2004 Aug 7. Cancer Biol Ther. 2004. PMID: 15280668 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous